Back to top

Strength Seen in Epizyme, Inc. (EPZM): Stock Shoots 75.6%
January 08, 2014

Read MoreHide Full Article

Epizyme, Inc. (EPZM - Free Report) was a big mover last session, as the company saw its shares escalate over 75% on the day. This significant jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock has risen about 65.8% in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate has remained static. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Epizyme currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Gentium S.p.A , and Forest Laboratories Inc. with a Zacks Rank #1 (Strong Buy) and Questcor Pharmaceuticals, Inc. with a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Epizyme, Inc. (EPZM) - free report >>

More from Zacks Tale of the Tape

You May Like